The NCCAPS study is designed to understand both the short- and long-term outcomes of both SARS-CoV-2 infection and cancer. Importantly, our study will also include banking of blood specimens and radiologic images. This will enable a more detailed exploration of disease pathology and has the potential to contribute to better understanding of the immunological impacts of infection in all patients.
SponsorsThis trial is sponsored by Children's Oncology Group.
Interested in Clinical Trial?
Providers Associated With This Trial
- Hamayun Imran, M.D.Pediatric Hematologist/OncologistProfessor of Pediatrics